The rationale for selecting these ABC transporters were: (1) ABCA1 has been widely studied as a cholesterol transporter, and platinum drugs commonly used for ovarian cancer are drug substrates for ABCA1[9]. This evidence concerns the gene ABCG2 and ovarian carcinoma.